NRXPW logo

NRx Pharmaceuticals (NRXPW) CAPEX

Annual CAPEX

$3000.00
-$7000.00-70.00%

December 31, 2023

Summary

Performance

1-Year Change

-70%

3-Year Change

+50%

5-Year Change

+100%

15-Year Change

+100%

NRXPW CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

0.99%
NRXPW annual capital expenditures is higher than 0.99% of companies in Healthcare sector

High & Low

All-time High

$10.00 K
NRXPW annual capital expenditures is currently -70.00% below its historical high of $10.00 thousand

3-Year Low

$3000.00
NRXPW annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NRXPW previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
NRXPW next annual earnings announcement has not yet been scheduled

OtherNRXPWcash flowmetrics:

Annual FCF

-$21.66 M
NRXPW annual free cash flow is -$21.66 million

Annual CFO

-$21.66 M
NRXPW annual cash flow from operations is -$21.66 million

Annual CFI

-$3000.00
NRXPW annual cash flow from investing activities is -$3000.00

Annual CFF

$6.20 M
NRXPW annual cash flow from financing activities is $6.20 million

Quarterly CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

NRXPW Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3829.00
NRXPW quarterly capital expenditures is currently at an all-time high

3-Year Low

$0.00
NRXPW quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NRXPW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
NRXPW next earnings announcement has not yet been scheduled

OtherNRXPWcash flowmetrics:

Quarterly FCF

-$2.31 M
NRXPW quarterly free cash flow is -$2.31 million

Quarterly CFO

-$2.31 M
NRXPW quarterly cash flow from operations is -$2.31 million

Quarterly CFI

$0.00
NRXPW quarterly cash flow from investing activities is $0.00

Quarterly CFF

$2.05 M
NRXPW quarterly cash flow from financing activities is $2.05 million

TTM CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

NRXPW TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9829.00
NRXPW TTM capital expenditures is currently at an all-time high

3-Year Low

$2000.00
NRXPW TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NRXPW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
NRXPW next earnings announcement has not yet been scheduled

OtherNRXPWcash flowmetrics:

TTM FCF

-$11.73 M
NRXPW TTM free cash flow is -$11.73 million

TTM CFO

-$11.73 M
NRXPW TTM cash flow from operations is -$11.73 million

TTM CFI

$1000.00
NRXPW TTM cash flow from investing activities is $1000.00

TTM CFF

$4.47 M
NRXPW TTM cash flow from financing activities is $4.47 million

NRXPW CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-70.0%--
3 y3 years+50.0%--
5 y5 years+100.0%--

NRXPW CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.0%at low
5 y5-year-70.0%-100.0%
alltimeall time-70.0%-100.0%

NRx Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Dec 2023
$3000.00(-70.0%)
-
-
Sep 2023
-
$2000.00(-33.3%)
$2000.00(-79.7%)
Dec 2022
$10.00 K(+42.9%)
-
-
Jun 2022
-
$3000.00(0.0%)
$9829.00(+43.9%)
Mar 2022
-
$3000.00(>+9900.0%)
$6829.00(+78.3%)
Dec 2021
$7000.00
$0.00(-100.0%)
$3829.00(0.0%)
Sep 2021
-
$3829.00(>+9900.0%)
$3829.00(>+9900.0%)
Jun 2021
-
$0.00(0.0%)
$0.00(0.0%)
DateAnnualQuarterlyTTM
Mar 2021
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2020
$2000.00(>+9900.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2020
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2019
$0.00
$0.00(0.0%)
$0.00(0.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2019
-
$0.00
$0.00

FAQ

  • What is NRx Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for NRx Pharmaceuticals?
  • What is NRx Pharmaceuticals annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for NRx Pharmaceuticals?
  • What is the all time high TTM CAPEX for NRx Pharmaceuticals?

What is NRx Pharmaceuticals annual capital expenditures?

The current annual CAPEX of NRXPW is $3000.00

What is the all time high annual CAPEX for NRx Pharmaceuticals?

NRx Pharmaceuticals all-time high annual capital expenditures is $10.00 K

What is NRx Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, NRXPW annual capital expenditures has changed by -$7000.00 (-70.00%)

What is the all time high quarterly CAPEX for NRx Pharmaceuticals?

NRx Pharmaceuticals all-time high quarterly capital expenditures is $3829.00

What is the all time high TTM CAPEX for NRx Pharmaceuticals?

NRx Pharmaceuticals all-time high TTM capital expenditures is $9829.00